Abstract:1. Tammy I. Kang, MD, MSCE* 2. David Munson, MD* 3. Jennifer Hwang, MD, MHS* 4. Chris Feudtner, MD, PhD, MPH* 1. *The Children’s Hospital of Philadelphia, Philadelphia, PA * Abbreviations: AAP: : American Academy of Pediatrics CCC: : concurrent care for children NICU: : neonatal intensive care unit PPC: : pediatric palliative care The 2013 American Academy of Pediatrics (AAP) Policy Statement “Pediatric Palliative Care and Hospice Care: Commitments, Guidelines, and Recommendations” urges broader integration of palliative care into overall medical care plans not only for terminally ill infants and children but also for those with life-threatening or life-shortening illnesses. Despite supportive federal legislation, the AAP recommendations have not been implemented consistently because of inadequate training, lack of funding, entrenched professional attitudes, and lack of an evidence base for assessments and interventions. To overcome these barriers, pediatric health care clinicians should educate themselves, their patients, their practices, and their health care systems on the benefits of earlier palliative care intervention. During the past decade the field of pediatric palliative care (PPC) has transformed. Palliative care services, once thought to be suitable only for patients in the last stages of life or reserved for patients engaging hospice services, are now being used much more broadly. No longer restricted to just the provision of end-of-life care, palliative care for children is now best understood as encompassing a combination of medical, psychosocial, and spiritual care that enables children with serious, life-threatening illnesses to maximize quality of life while making medical decisions based on the goals and values of the patient and family. Integrating palliative care into the overall plan of medical care for children with serious illness is a key therapeutic goal. In 2013, the American Academy of Pediatrics (AAP) published a policy statement entitled “Pediatric Palliative Care and Hospice Care: Commitments, Guidelines, and Recommendations” that aimed to promote the welfare of infants and children living with life-threatening or inevitably life-shortening conditions and their …

Enantioselective Total Synthesis of Lycopodine

Total Syntheses of Lycoposerramine-V and 5-Epi-lycoposerramine-v.

Enantioselective Total Synthesis of Lycoposerramine-Z Using Chiral Phosphoric Acid Catalyzed Intramolecular Michael Addition

Enantioselective total synthesis of lycoposerramine W through late-stage nitrogen deletion

Collective Synthesis of Lycopodium Alkaloids and Tautomer Locking Strategy for the Total Synthesis of (-)-lycojapodine A

Enantioselective Total Synthesis of (+)-Steenkrotin A and Determination of Its Absolute Configuration.

Enantioselective Total Synthesis of (+)-Sieboldine A and Analogues Thereof

Enantioselective Total Synthesis of (+)-Cylindricine B

Enantioselective Allenation of Terminal Alkynes Catalyzed by Copper Halides of Mixed Oxidation States and Its Application to the Total Synthesis of Scorodonin.

Integration of palliative care into the care of children with serious illness.

Protecting Group-Free Total Synthesis of (-)-lannotinidine B

Enantioselective Synthesis of the 1,3‐Dienyl‐5‐alkyl‐6‐oxy Motif: Method Development and Total Synthesis

Enantioselective Total Synthesis of (-)-Zygadenine

Enantioselective Total Synthesis of (-)-Hunterine A Enabled by a Desymmetrization/Rearrangement Strategy

Divergent Total Syntheses of (-)-lycopladine D, (+)-Fawcettidine, and (+)-Lycoposerramine Q

Total Synthesis Of (-)-Goniomitine

Enantioselective Total Synthesis of (-)-Cyathin B 2 : A Desymmetric Double-Allylboration Approach

Total synthesis of (-)-rhynchine A, (+)-rhynchine C and (+)-rhynchine E

Asymmetric Total Synthesis of (−)-Lingzhiol Via a Rh-catalysed [3+2] Cycloaddition

Enantioselective and Collective Total Syntheses of Xanthanolides

Enantioselective Total Syntheses of Pallambins A–D